What should investors watch in the NUMI.TO stock earnings report on Jan 19 2026?

Focus on revenue by division, clinic utilization, lab service margins, and cash flow. Any guidance on capital needs or expected clinic rollouts will likely move the share price.

Is NUMI.TO stock profitable and what are the key financial ratios?

Numinus is not profitable on a trailing basis with EPS **-0.08** and a negative P/E. The current ratio is **0.61**, and cash per share is minimal, indicating tight liquidity.

What is Meyka AI's short-term forecast for NUMI.TO?

Meyka AI's forecast model projects a reference target of **C$0.08** versus the current **C$0.05**, implying roughly **60.00%** upside. Forecasts are model-based projections and not guarantees.

How liquid is trading in NUMI.TO and how might earnings affect price?

Average volume is **184,378.00** but recent volume hit **989,752.00**, so liquidity can spike. Earnings may trigger large moves because the market cap is small.

CA Stocks

NUMINUS (NUMI.TO TSX) C$0.05 pre-market Jan 2026: earnings Jan 19 to watch

ByHuzaifa Zahoor January 14, 2026January 14, 2026

We note NUMI.TO stock trading at C$0.05 in pre-market on 14 Jan 2026 as the company prepares to report earnings on 19 Jan 2026. Volume has already risen to 989,752.00 shares, well above the 50-day average. Investors will watch top-line trends and cash flow after Numinus announced improved operating cash flow growth in FY 2024. This earnings spotlight frames short-term price risk and a possible catalyst for a volatile session when the company issues results and guidance.